The latest quarterly R&D expense is $94.98 Million with a QoQ Growth of +32.87%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2027 (2026-07-31).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2027 (2026-07-31): $94.98M.
$94.98M
$94.98 Million
Q2 FY2027 · 2026-07-31
+32.87%
vs. $71.48M prior quarter
26
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2027Period end 2026-07-31 | $94.98M | +32.87% | +32.86% |
| Q1 FY2027Period end 2026-04-30 | $71.48M | +3.66% | +9.28% |
| Q4 FY2026Period end 2026-01-31 | $68.96M | +0.36% | +9.66% |
| Q3 FY2026Period end 2025-10-31 | $68.72M | -3.88% | +12.00% |
| Q2 FY2026Period end 2025-07-31 | $71.49M | +9.29% | +16.67% |
| Q1 FY2026Period end 2025-04-30 | $65.41M | +4.02% | +20.82% |
| Q4 FY2025Period end 2025-01-31 | $62.88M | +2.50% | +20.04% |
| Q3 FY2025Period end 2024-10-31 | $61.35M | +0.13% | +25.06% |
| Q2 FY2025Period end 2024-07-31 | $61.27M | +13.18% | +25.03% |
| Q1 FY2025Period end 2024-04-30 | $54.14M | +3.34% | +7.45% |
| Q4 FY2024Period end 2024-01-31 | $52.39M | +6.79% | +19.94% |
| Q3 FY2024Period end 2023-10-31 | $49.06M | +0.10% | +19.32% |
| Q2 FY2024Period end 2023-07-31 | $49.01M | -2.74% | +24.01% |
| Q1 FY2024Period end 2023-04-30 | $50.39M | +15.35% | +58.30% |
| Q4 FY2023Period end 2023-01-31 | $43.68M | +6.24% | +52.67% |
| Q3 FY2023Period end 2022-10-31 | $41.11M | +4.03% | +66.69% |
| Q2 FY2023Period end 2022-07-31 | $39.52M | +24.16% | +74.84% |
| Q1 FY2023Period end 2022-04-30 | $31.83M | +11.25% | +49.16% |
| Q4 FY2022Period end 2022-01-31 | $28.61M | +16.00% | -41.25% |
| Q3 FY2022Period end 2021-10-31 | $24.66M | +9.12% | +29.52% |
| Q2 FY2022Period end 2021-07-31 | $22.60M | +5.92% | +14.17% |
| Q1 FY2022Period end 2021-04-30 | $21.34M | -56.18% | +11.71% |
| Q4 FY2021Period end 2021-01-31 | $48.70M | +155.76% | N/A |
| Q3 FY2021Period end 2020-10-31 | $19.04M | -3.81% | N/A |
| Q2 FY2021Period end 2020-07-31 | $19.80M | +3.63% | N/A |
| Q1 FY2021Period end 2020-04-30 | $19.10M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
